{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T05:44:01Z","timestamp":1774676641096,"version":"3.50.1"},"reference-count":0,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1988,1]]},"DOI":"10.1212\/wnl.38.1.81","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T12:44:06Z","timestamp":1336913046000},"page":"81-81","update-policy":"https:\/\/doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":14,"title":["Serologic studies of MS patients, controls, and patients with other neurologic diseases"],"prefix":"10.1212","volume":"38","author":[{"given":"D. L.","family":"Madden","sequence":"first","affiliation":[{"name":"National Institute of Neurological and Communicative Disorders and Stroke (Drs. Madden, Dalakas, and Sever, and Ms. Tzan), National Institutes of Health, Bethesda; Electronucleonics (Mr. Mundon), Columbia; and Microbiological Associates (Dr. Fuccillo). Bethesda, MD; the Medical College of Virginia (Dr. Calabrese), Richmond, VA; and the Mount Sinai Medical Center (Dr. Elizan), New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. K.","family":"Mundon","sequence":"additional","affiliation":[{"name":"National Institute of Neurological and Communicative Disorders and Stroke (Drs. Madden, Dalakas, and Sever, and Ms. Tzan), National Institutes of Health, Bethesda; Electronucleonics (Mr. Mundon), Columbia; and Microbiological Associates (Dr. Fuccillo). Bethesda, MD; the Medical College of Virginia (Dr. Calabrese), Richmond, VA; and the Mount Sinai Medical Center (Dr. Elizan), New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. R.","family":"Tzan; D. A. Fuccillo","sequence":"additional","affiliation":[{"name":"National Institute of Neurological and Communicative Disorders and Stroke (Drs. Madden, Dalakas, and Sever, and Ms. Tzan), National Institutes of Health, Bethesda; Electronucleonics (Mr. Mundon), Columbia; and Microbiological Associates (Dr. Fuccillo). Bethesda, MD; the Medical College of Virginia (Dr. Calabrese), Richmond, VA; and the Mount Sinai Medical Center (Dr. Elizan), New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. C.","family":"Dalakas","sequence":"additional","affiliation":[{"name":"National Institute of Neurological and Communicative Disorders and Stroke (Drs. Madden, Dalakas, and Sever, and Ms. Tzan), National Institutes of Health, Bethesda; Electronucleonics (Mr. Mundon), Columbia; and Microbiological Associates (Dr. Fuccillo). Bethesda, MD; the Medical College of Virginia (Dr. Calabrese), Richmond, VA; and the Mount Sinai Medical Center (Dr. Elizan), New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Calabrese","sequence":"additional","affiliation":[{"name":"National Institute of Neurological and Communicative Disorders and Stroke (Drs. Madden, Dalakas, and Sever, and Ms. Tzan), National Institutes of Health, Bethesda; Electronucleonics (Mr. Mundon), Columbia; and Microbiological Associates (Dr. Fuccillo). Bethesda, MD; the Medical College of Virginia (Dr. Calabrese), Richmond, VA; and the Mount Sinai Medical Center (Dr. Elizan), New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. S.","family":"Elizan","sequence":"additional","affiliation":[{"name":"National Institute of Neurological and Communicative Disorders and Stroke (Drs. Madden, Dalakas, and Sever, and Ms. Tzan), National Institutes of Health, Bethesda; Electronucleonics (Mr. Mundon), Columbia; and Microbiological Associates (Dr. Fuccillo). Bethesda, MD; the Medical College of Virginia (Dr. Calabrese), Richmond, VA; and the Mount Sinai Medical Center (Dr. Elizan), New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. L.","family":"Sever","sequence":"additional","affiliation":[{"name":"National Institute of Neurological and Communicative Disorders and Stroke (Drs. Madden, Dalakas, and Sever, and Ms. Tzan), National Institutes of Health, Bethesda; Electronucleonics (Mr. Mundon), Columbia; and Microbiological Associates (Dr. Fuccillo). Bethesda, MD; the Medical College of Virginia (Dr. Calabrese), Richmond, VA; and the Mount Sinai Medical Center (Dr. Elizan), New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.38.1.81","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T11:59:28Z","timestamp":1711540768000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.38.1.81"}},"subtitle":["Antibodies to HTLV\u2010I, II, III"],"short-title":[],"issued":{"date-parts":[[1988,1]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1988,1]]}},"alternative-id":["10.1212\/WNL.38.1.81"],"URL":"https:\/\/doi.org\/10.1212\/wnl.38.1.81","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1988,1]]}}}